Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
Rhea-AI Summary
Tarsus (NASDAQ: TARS) will report third quarter 2025 financial results on Tuesday, November 4, 2025. The company will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET to present results and a corporate update.
Participants may access the live webcast online; a recorded version will be posted on the company website shortly after the call and archived for approximately 90 days.
Positive
- None.
Negative
- None.
News Market Reaction – TARS
In the Oct 29 session, TARS declined 0.06%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Tuesday, November 4, 2025 to report its third quarter 2025 financial results and provide a corporate update.
Participants may access the webcast here. A recorded version of the call will be available on the website shortly after the completion of the webcast and will be archived there for approximately 90 days.
About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care and infectious disease prevention. XDEMVY® (lotilaner ophthalmic solution)
| Media Contact: |
| Adrienne Kemp |
| Sr. Director, Corporate Communications |
| (949) 922-0801 |
| AKemp@tarsusrx.com |
| Investor Contact: |
| David Nakasone |
| Head of Investor Relations |
| (949) 620-3223 |
| DNakasone@tarsusrx.com |
